Literature DB >> 8097569

Interactions of methylenedioxymethamphetamine with monoamine transmitter release mechanisms in rat brain slices.

J L Fitzgerald1, J J Reid.   

Abstract

This study investigates the effects of methylenedioxymethamphetamine (MDMA) and amphetamine on monoamine release from rat superfused brain slices in both the presence and absence of vesicular stores of transmitter. MDMA caused the release of radioactivity from slices incubated with [3H]5-hydroxytryptamine, [3H]noradrenaline or [3H]dopamine with EC50 values of 1.9 mumol/l (95% confidence limits 1.5-2.3 mumol/l), 4.5 mumol/l (2.3-8.7 mumol/l), and greater than 30 mumol/l, respectively. In contrast, amphetamine (0.1-300 mumol/l) was more effective in releasing radioactivity from slices incubated with [3H]dopamine than [3H]noradrenaline or [3H]5-hydroxytryptamine. When Ca2+ was excluded from the superfusion fluid, the MDMA-induced release of radioactivity from slices incubated with [3H]dopamine was unaltered, but that from slices incubated with [3H]noradrenaline or [3H]5-hydroxytryptamine was enhanced. MDMA (10 mumol/l) facilitated the stimulation-induced (5 Hz, 1 min) outflow of radioactivity from slices incubated with [3H]noradrenaline or [3H]5-hydroxytryptamine to 7.5-fold and 2.1-fold of control values, respectively, but had no effect on that from slices incubated with [3H]dopamine. Amphetamine (1 mumol/l) increased the stimulation-induced outflow from slices incubated with [3H]noradrenaline, but not that from slices incubated with [3H]5-hydroxytryptamine or [3H]dopamine. Inhibition of monoamine oxidase by a 30-min incubation with pargyline (100 mumol/l) enhanced the releasing action of MDMA on all three monoamines. Pargyline (100 mumol/l) also enhanced the facilitation caused by MDMA, of the stimulation-induced outflow of radioactivity from slices incubated with [3H]noradrenaline, [3H]5-hydroxytryptamine or [3H]dopamine. In some experiments, slices were obtained from reserpinised rats (2.5 mg/kg s.c. 24 h prior) and pre-exposed for 30 min to the monoamine oxidase inhibitor parglyine (100 mumol/l). Under these conditions, electrical stimulation evoked a small residual stimulation-induced outflow of radioactivity from slices incubated with [3H]noradrenaline, and failed to evoke an outflow of radioactivity from slices incubated with [3H]5-hydroxytryptamine or [3H]dopamine. However, a Ca(2+)-dependent stimulation-induced outflow of radioactivity was evoked in the presence of either MDMA (10 mumol/l) or amphetamine (1 mumol/l) from slices incubated with either [3H]dopamine or [3H]noradrenaline, but not from slices incubated with [3H]5-hydroxytryptamine. The stimulation-induced outflow of radioactivity from slices incubated with [3H]noradrenaline was enhanced in the presence of desipramine (1 mumol/l), however this enhancement was less than that caused by 10 mumol/l MDMA or 1 mumol/l amphetamine. The Ca(2+)-dependent response to electrical stimulation in the presence of MDMA from slices incubated with [3H]noradrenaline was greatly reduced when rats were pretreated with a higher dose of reserpine (10 mg/kg s.c.).(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8097569     DOI: 10.1007/bf00167451

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  48 in total

1.  Release of serotonin and catecholamines by drugs.

Authors:  P A SHORE
Journal:  Pharmacol Rev       Date:  1962-12       Impact factor: 25.468

2.  Chemical release of dopamine from striatal homogenates: evidence for an exchange diffusion model.

Authors:  J F Fischer; A K Cho
Journal:  J Pharmacol Exp Ther       Date:  1979-02       Impact factor: 4.030

3.  Physico-chemical properties of phenethylamines and their uptake into synaptic vesicles of the caudate nucleus.

Authors:  H Lentzen; A Philippu
Journal:  Biochem Pharmacol       Date:  1981-07-01       Impact factor: 5.858

4.  Effect of dopamine receptor agonists and antagonists on release of dopamine in the rabbit caudate nucleus in vitro.

Authors:  K Starke; W Reimann; A Zumstein; G Hertting
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-10       Impact factor: 3.000

5.  d-Amphetamine as a releaser or reuptake inhibitor of biogenic amines in synaptosomes.

Authors:  M Raiteri; A Bertollini; F Angelini; G Levi
Journal:  Eur J Pharmacol       Date:  1975-11       Impact factor: 4.432

6.  Pathways of dopamine metabolism in the rabbit caudate nucleus in vitro.

Authors:  A Zumstein; W Karduck; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-06       Impact factor: 3.000

7.  [3H]Dopamine release by d-amphetamine from striatal synaptosomes of reserpinized rats.

Authors:  D T Masuoka; A F Alcaraz; H F Schott
Journal:  Biochem Pharmacol       Date:  1982-06-01       Impact factor: 5.858

8.  Effects of racemic, (S)- and (R)-methylenedioxyamphetamine on synaptosomal uptake and release of tritiated norepinephrine.

Authors:  G M Marquardt; V DiStefano; L L Ling
Journal:  Biochem Pharmacol       Date:  1978-05-15       Impact factor: 5.858

9.  Biochemical and histological evidence that methylenedioxymethylamphetamine (MDMA) is toxic to neurons in the rat brain.

Authors:  D L Commins; G Vosmer; R M Virus; W L Woolverton; C R Schuster; L S Seiden
Journal:  J Pharmacol Exp Ther       Date:  1987-04       Impact factor: 4.030

10.  3,4-Methylenedioxyamphetamine (MDA) analogues exhibit differential effects on synaptosomal release of 3H-dopamine and 3H-5-hydroxytryptamine.

Authors:  D J McKenna; X M Guan; A T Shulgin
Journal:  Pharmacol Biochem Behav       Date:  1991-03       Impact factor: 3.533

View more
  13 in total

1.  Investigation of the prejunctional alpha2-adrenoceptor mediated actions of MDMA in rat atrium and vas deferens.

Authors:  A Lavelle; V Honner; J R Docherty
Journal:  Br J Pharmacol       Date:  1999-11       Impact factor: 8.739

Review 2.  The role of monoamines in the changes in body temperature induced by 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) and its derivatives.

Authors:  J R Docherty; A R Green
Journal:  Br J Pharmacol       Date:  2010-07       Impact factor: 8.739

3.  Vascular actions of MDMA involve alpha1 and alpha2-adrenoceptors in the anaesthetized rat.

Authors:  J McDaid; J R Docherty
Journal:  Br J Pharmacol       Date:  2001-06       Impact factor: 8.739

4.  The mechanisms involved in the long-lasting neuroprotective effect of fluoxetine against MDMA ('ecstasy')-induced degeneration of 5-HT nerve endings in rat brain.

Authors:  V Sanchez; J Camarero; B Esteban; M J Peter; A R Green; M I Colado
Journal:  Br J Pharmacol       Date:  2001-09       Impact factor: 8.739

5.  Vesicular monoamine transporter 2 and the acute and long-term response to 3,4-(±)-methylenedioxymethamphetamine.

Authors:  Lucina E Lizarraga; Aram B Cholanians; Andy V Phan; Joseph M Herndon; Serrine S Lau; Terrence J Monks
Journal:  Toxicol Sci       Date:  2014-11-04       Impact factor: 4.849

Review 6.  3,4-Methylenedioxymethamphetamine (MDMA) neurotoxicity in rats: a reappraisal of past and present findings.

Authors:  Michael H Baumann; Xiaoying Wang; Richard B Rothman
Journal:  Psychopharmacology (Berl)       Date:  2006-03-16       Impact factor: 4.530

7.  Neural and cardiac toxicities associated with 3,4-methylenedioxymethamphetamine (MDMA).

Authors:  Michael H Baumann; Richard B Rothman
Journal:  Int Rev Neurobiol       Date:  2009       Impact factor: 3.230

8.  Endogenous serotonin facilitates hippocampal long-term potentiation at CA3/CA1 synapses.

Authors:  Boris Mlinar; Gabriella Stocca; Renato Corradetti
Journal:  J Neural Transm (Vienna)       Date:  2014-05-29       Impact factor: 3.575

9.  Alpha1-adrenergic receptors mediate the locomotor response to systemic administration of (+/-)-3,4-methylenedioxymethamphetamine (MDMA) in rats.

Authors:  Jennifer Selken; David E Nichols
Journal:  Pharmacol Biochem Behav       Date:  2007-02-16       Impact factor: 3.533

10.  Serotonin reuptake transporter deficiency modulates the acute thermoregulatory and locomotor activity response to 3,4-(±)-methylenedioxymethamphetamine, and attenuates depletions in serotonin levels in SERT-KO rats.

Authors:  Lucina E Lizarraga; Andy V Phan; Aram B Cholanians; Joseph M Herndon; Serrine S Lau; Terrence J Monks
Journal:  Toxicol Sci       Date:  2014-03-04       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.